We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
-13.22%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.1B
AUM Growth
-$3.31B
(-16%)
Cap. Flow
-$374M
Cap. Flow
% of AUM
-2.19%
Top 10 Holdings %
Top 10 Hldgs %
19.96%
Holding
1,420
New
91
Increased
417
Reduced
597
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$69.4M |
| 2 |
Ulta Beauty
ULTA
|
+$54.9M |
| 3 |
Lockheed Martin
LMT
|
+$54M |
| 4 |
Advanced Micro Devices
AMD
|
+$53.7M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$53M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$52.3M |
| 3 |
Take-Two Interactive
TTWO
|
+$47.9M |
| 4 |
eBay
EBAY
|
+$44.3M |
| 5 |
Cardinal Health
CAH
|
+$35.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.22% |
| 2 | Healthcare | 14.4% |
| 3 | Financials | 10.22% |
| 4 | Consumer Discretionary | 8.43% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Cushman & Wakefield Ltd
CWK
$2.98B
| $13.8M | 0.08% |
902,734
+81,706
| +10% | +$1.44M |
|
277
Mesa Laboratories
MLAB
$539M
| $13.7M | 0.08% |
67,018
-6,254
| -9% | -$1.37M |
|
278
Dycom Industries
DY
$12.9B
| $13.6M | 0.08% |
146,606
-15,790
| -10% | -$1.41M |
|
279
Helmerich & Payne
HP
$3.53B
| $13.6M | 0.08% |
+315,788
| New | +$14.7M |
|
|
DOOR
280
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $13.6M | 0.08% |
176,765
-18,515
| -9% | -$1.52M |
|
281
Boise Cascade
BCC
$2.74B
| $13.5M | 0.08% |
227,765
-24,603
| -10% | -$1.82M |
|
282
Rambus
RMBS
$10.4B
| $13.4M | 0.08% |
624,780
-68,115
| -10% | -$1.68M |
|
283
Morgan Stanley
MS
$337B
| $13.4M | 0.08% |
175,871
+121
| +0.1% | +$9.91K |
|
284
Broadcom
AVGO
$1.82T
| $13.3M | 0.08% |
274,310
+2,950
| +1% | +$166K |
|
285
Stewart Information Services
STC
$2.05B
| $13.3M | 0.08% |
267,459
-28,735
| -10% | -$1.54M |
|
286
Pacira BioSciences
PCRX
$1.02B
| $13.3M | 0.08% |
227,969
-24,764
| -10% | -$1.62M |
|
287
Danaher
DHR
$135B
| $13.3M | 0.08% |
59,001
+4,673
| +9% | +$1.08M |
|
288
Ingevity
NGVT
$2.55B
| $13.3M | 0.08% |
209,930
-22,998
| -10% | -$1.5M |
|
|
JNPR
289
DELISTED
Juniper Networks
JNPR
| $13.2M | 0.08% |
463,572
+190,982
| +70% | +$6.02M |
|
|
NUVA
290
DELISTED
NuVasive, Inc.
NUVA
| $13.1M | 0.08% |
267,205
-28,741
| -10% | -$1.54M |
|
291
Kroger
KR
$34.8B
| $13.1M | 0.08% |
276,849
+26,097
| +10% | +$1.39M |
|
292
New Jersey Resources
NJR
$6.06B
| $13.1M | 0.08% |
293,969
-31,077
| -10% | -$1.4M |
|
293
Kontoor Brands
KTB
$4.62B
| $13M | 0.08% |
+390,845
| New | +$15.2M |
|
294
Westlake Corp
WLK
$9.46B
| $13M | 0.08% |
132,902
-1,786
| -1% | -$219K |
|
295
GoDaddy
GDDY
$12.3B
| $13M | 0.08% |
186,570
+62,623
| +51% | +$4.76M |
|
296
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $12.8M | 0.08% |
282,850
-1,480
| -0.5% | -$73.1K |
|
297
ServiceNow
NOW
$102B
| $12.8M | 0.07% |
134,095
-10,325
| -7% | -$984K |
|
298
TE Connectivity
TEL
$58.8B
| $12.7M | 0.07% |
112,533
-4,399
| -4% | -$545K |
|
299
Estee Lauder
EL
$29B
| $12.7M | 0.07% |
49,933
-8,075
| -14% | -$2.05M |
|
300
Teradyne
TER
$54.8B
| $12.7M | 0.07% |
141,545
-3,828
| -3% | -$398K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q2 2022 Portfolio in Review
As of Q2 2022, Glenmede Trust held 1,420 positions worth $17.1B, down 16% from $20.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Glenmede Trust's Q2 2022 filing shows 91 new, 417 increased, 597 reduced and 121 closed positions. Its largest new stake was Pinterest: 974,820 shares worth $17.7M. The largest sale was Accenture, an estimated $53M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Glenmede Trust's largest Q2 2022 buy was Pinterest: 974,820 shares worth $17.7M.
- Glenmede Trust added most to Vanguard Total Stock Market ETF in Q2 2022, an estimated $69.4M increase.
- Glenmede Trust's biggest Q2 2022 reduction was Accenture, cutting an estimated $53M.
- Glenmede Trust fully exited Ovintiv in Q2 2022, selling an estimated $35M.
- Glenmede Trust's ten largest holdings make up 20% of its $17.1B portfolio in Q2 2022.
- Glenmede Trust opened 91 new positions and closed 121 in Q2 2022.
- Glenmede Trust's portfolio value fell 16% quarter-over-quarter to $17.1B.
Based on Glenmede Trust's 13F filing for Q2 2022, filed 15 Aug 2022.